NVO
Novo Nordisk A/S [NVO] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NVO Stock Summary
Top NVO Correlated Resources
NVO
Top 10 Correlated ETFs
NVO
Top 10 Correlated Stocks
NVO
In the News
NVO Financial details
NVO Financial Performance
NVO Frequently Asked Questions
What is Novo Nordisk A/S stock symbol ?
Novo Nordisk A/S is a DK stock and trading under the symbol NVO
What is Novo Nordisk A/S stock quote today ?
Novo Nordisk A/S stock price is $64.73 today.
Is Novo Nordisk A/S stock public?
Yes, Novo Nordisk A/S is a publicly traded company.
Company Profile
- Volume Average 5.1M
- Market Capitalization 555.41B
- Employee 63.37K
- CEO Mr. Lars Fruergaard Jorgensen
- Headquarters Bagsvaerd,DK
- IPO Date 1981-04-30
-
Website
https://www.novonordisk.com 
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
